Emblem Oils Now Available Through Shoppers Drug Mart
January 08 2019 - 8:55AM
Emblem Corp. (TSXV: EMC, OTCQX: EMMBF)
(“Emblem” or the “Company”) through its wholly-owned subsidiary
Emblem Cannabis Corporation, today announced that Emblem-branded
cannabis oils are now available online through Shoppers Drug Mart
to patients with a valid medical authorization.
“As a patient-first provider, Emblem is committed to helping
provide patients access to our products through distribution
channels that provide both care and convenience like Shoppers Drug
Mart,” said Nick Dean, CEO, Emblem Corp. “Accessing a variety of
distribution channels also continues to be a critical factor in our
business strategy as we remain focused on being a leader in the
medical cannabis space.”
About Emblem Emblem is a fully integrated
cannabis company focused on driving shareholder value through
product innovation, brand relevance, and access to patient and
consumer channels. Through its wholly-owned subsidiary Emblem
Cannabis Corporation, Emblem is licensed to cultivate, process, and
sell cannabis and cannabis derivatives in Canada under
the Cannabis Act. Emblem’s state-of-the-art indoor cannabis
cultivation facility and Product Innovation Centre is located in
Paris, Ontario. Emblem is also the parent company of GrowWise
Health Limited, one of Canada’s leading cannabis education
services. Emblem trades under the ticker symbol EMC on the TSX
Venture Exchange.
For more information, please
visit www.emblemcorp.com.
For media inquiries, please contact:Deborah
RoweH+K Strategies416.413.4780Deborah.Rowe@hkstrategies.ca
For investor inquiries, please contact:Ethan
Karayannopoulos Investor Relations Emblem Corp. 647.748.9696
ethank@emblemcorp.com
Alex Stojanovic Chief Financial Officer Emblem Corp.
416.923.1331 alexs@emblemcorp.com
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATIONThis
news release contains certain forward-looking statements and
forward-looking information (collectively referred to herein as
“forward-looking statements”) within the meaning of applicable
Canadian securities laws. All statements other than statements of
present or historical fact are forward-looking statements.
Forward-looking statements are often, but not always, identified by
the use of words such as “anticipate”, “achieve”, “could”,
“believe”, “plan”, “intend”, “objective”, “continuous”, “ongoing”,
“estimate”, “outlook”, “expect”, “may”, “will”, “project”, “should”
or similar words, including negatives thereof, suggesting future
outcomes. Management of the Company believes the expectations
reflected in such forward-looking statements are reasonable as of
the date hereof but no assurance can be given that these
expectations will prove to be correct and such forward-looking
statements should not be unduly relied upon. Various material
factors and assumptions are typically applied in drawing
conclusions or making the forecasts or projections set out in
forward-looking statements. Those material factors and assumptions
are based on information currently available to the Company,
including data from publicly available governmental sources as well
as from market research and industry analysis and on assumptions
based on data and knowledge of this industry which Emblem believes
to be reasonable. However, although generally indicative of
relative market positions, market shares and performance
characteristics, such data is inherently imprecise. While Emblem is
not aware of any misstatement regarding any industry or government
data presented herein, the medical marijuana industry involves
risks and uncertainties and is subject to change based on various
factors.
Forward-looking statements are not a guarantee of future
performance and are subject to and involve a number of known and
unknown risks and uncertainties, many of which are beyond the
control of the Company, which may cause the Company’s actual
performance and results to differ materially from any projections
of future performance or results expressed or implied by such
forward-looking statements. These risks and uncertainties include,
but are not limited to, the risks identified in the Company’s
December 31, 2017 Management’s Discussion and Analysis, which has
been filed with the Canadian Securities Administrators and
available on www.sedar.com. Any forward-looking statements are made
as of the date hereof and, except as required by law, the Company
assumes no obligation to publicly update or revise such statements
to reflect new information, subsequent or otherwise.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this press release.
Emblem Corp (TSXV:EMC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Emblem Corp (TSXV:EMC)
Historical Stock Chart
From Jul 2023 to Jul 2024